<html>
<head>PUBMED IDs for CCN6</head>
<body bgcolor='#C5F0F2'><h1>CCN6</h1><a href='https://pubmed.ncbi.nlm.nih.gov/2839716/'>Regulation of human papillomavirus type 11 enhancer and E6 promoter by activating and repressing proteins from the E2 open reading frame: functional and biochemical studies.</a> August 1  1988<br><a href='https://pubmed.ncbi.nlm.nih.gov/2154890/'>The DNA-binding domain of HPV-16 E2 protein interaction with the viral enhancer: protein-induced DNA bending and role of the nonconserved core sequence in binding site affinity.</a> February 1  1990<br><a href='https://pubmed.ncbi.nlm.nih.gov/8289341/'>Human papillomavirus type 11 E2 proteins repress the homologous E6 promoter by interfering with the binding of host transcription factors to adjacent elements.</a> February 1  1994<br><a href='https://pubmed.ncbi.nlm.nih.gov/9733852/'>Transactivation by the E2 protein of oncogenic human papillomavirus type 31 is not essential for early and late viral functions.</a> September 12  1998<br><a href='https://pubmed.ncbi.nlm.nih.gov/12446788/'>CYR61 (CCN1) is essential for placental development and vascular integrity.</a> November 26  2002<br><a href='https://pubmed.ncbi.nlm.nih.gov/15611078/'>Integrin-dependent functions of the angiogenic inducer NOV (CCN3): implication in wound healing.</a> December 22  2004<br><a href='https://pubmed.ncbi.nlm.nih.gov/15631777/'>[Pathology and molecular pathogenesis of spondyloepiphyseal dysplasia tarda with progressive arthropathy caused by compound CCN6 heterogeneous gene mutations].</a> January 6  2005<br><a href='https://pubmed.ncbi.nlm.nih.gov/15773998/'>Differential expression of CCN-family members in primary human bone marrow-derived mesenchymal stem cells during osteogenic, chondrogenic and adipogenic differentiation.</a> March 19  2005<br><a href='https://pubmed.ncbi.nlm.nih.gov/16457688/'>Inhibition of CCN6 (WISP3) expression promotes neoplastic progression and enhances the effects of insulin-like growth factor-1 on breast epithelial cells.</a> February 7  2006<br><a href='https://pubmed.ncbi.nlm.nih.gov/17587813/'>CCN6 (WISP3) as a new regulator of the epithelial phenotype in breast cancer.</a> June 26  2007<br><a href='https://pubmed.ncbi.nlm.nih.gov/18321996/'>Inhibition of CCN6 (Wnt-1-induced signaling protein 3) down-regulates E-cadherin in the breast epithelium through induction of snail and ZEB1.</a> March 7  2008<br><a href='https://pubmed.ncbi.nlm.nih.gov/19128405/'>Role of CCN, a vertebrate specific gene family, in development.</a> March 24  2009<br><a href='https://pubmed.ncbi.nlm.nih.gov/19128366/'>Molecular analysis of novel PROP1 mutations associated with combined pituitary hormone deficiency (CPHD).</a> August 4  2009<br><a href='https://pubmed.ncbi.nlm.nih.gov/19319669/'>Expression of CCN family of genes in human skin in vivo and alterations by solar-simulated ultraviolet irradiation.</a> March 26  2009<br><a href='https://pubmed.ncbi.nlm.nih.gov/19370402/'>Ten years later...</a> April 17  2009<br><a href='https://pubmed.ncbi.nlm.nih.gov/21391218/'>CCN6 enhances ICAM-1 expression and cell motility in human chondrosarcoma cells.</a> December 13  2011<br><a href='https://pubmed.ncbi.nlm.nih.gov/21525039/'>CCN6 (WISP3) decreases ZEB1-mediated EMT and invasion by attenuation of IGF-1 receptor signaling in breast cancer.</a> November 4  2011<br><a href='https://pubmed.ncbi.nlm.nih.gov/21525025/'>Regulation of adverse remodelling by osteopontin in a genetic heart failure model.</a> December 10  2011<br><a href='https://pubmed.ncbi.nlm.nih.gov/22294415/'>Dual regulation of metalloproteinase expression in chondrocytes by Wnt-1-inducible signaling pathway protein 3/CCN6.</a> September 15  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/23226100/'>CCN6 knockdown disrupts acinar organization of breast cells in three-dimensional cultures through up-regulation of type III TGF-β receptor.</a> May 17  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/24168183/'>Decoding the knots of initiation of oncogenic epithelial-mesenchymal transition in tumor progression.</a> August 13  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/24168170/'>Loss of WSTF results in spontaneous fluctuations of heterochromatin formation and resolution, combined with substantial changes to gene expression.</a> December 17  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/25400723/'>Silencing of WISP3 suppresses gastric cancer cell proliferation and metastasis and inhibits Wnt/β-catenin signaling.</a> July 15  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/25400706/'>Identifying diagnostic DNA methylation profiles for facioscapulohumeral muscular dystrophy in blood and saliva using bisulfite sequencing.</a> November 18  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/25738435/'>Identification of a mutation in the WISP3 gene in three unrelated families with progressive pseudorheumatoid dysplasia.</a> January 1  2015<br><a href='https://pubmed.ncbi.nlm.nih.gov/27819674/'>MMTV-cre;Ccn6 knockout mice develop tumors recapitulating human metaplastic breast carcinomas.</a> November 8  2016<br><a href='https://pubmed.ncbi.nlm.nih.gov/27877210/'>In vivo Antitumor Effect of an HPV-specific Promoter driving IL-12 Expression in an HPV 16-positive Murine Model of Cervical Cancer.</a> November 24  2016<br></body></html>
